ANASTASIA ROSE: Open Payments
NPI 1992313688 · PERTH AMBOY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 28 payments from 13 companies in 2025. Trend: 2023 $232 · 2024 $209 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $189 |
| Galderma Laboratories, L.P. | 2 | $162 |
| Botanix SB Inc | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $51 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $48 |
| Almirall LLC | 2 | $43 |
| Janssen Biotech, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: RINVOQ, NEMLUVIO, SOFDRA, COSENTYX, Cabtreo, Klisyri, SKYRIZI, TREMFYA.
Industry payments across NJ — which companies pay providers there.
